Sisram Medical to Review 1H 2026 Interim Results and Potential Dividend on 19 August 2026
Bulletin Express
Aug 05
Sisram Medical Ltd has scheduled a board meeting for 19 August 2026 to consider and approve the group’s interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend, if any, and other corporate matters.
The meeting will be chaired by Lior Moshe Dayan, who serves as chairman and executive director. The current board comprises two executive directors, three non-executive directors and four independent non-executive directors, providing a balanced governance structure ahead of the upcoming results review.
The announcement was released in Hong Kong on 5 August 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.